ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY FOR TREATMENT OF CD20 POSITIVE DISEASES

• Main Authors: YU, Jin-Chen, ZHOU, Yuanqing, ZHANG, Li, LIU, Cuihua, QI, Yunpeng, XIAO, Cuizhen, HUANG, Dandan, WU, Yong, LI, Shengfeng, CHEN, Yanyu, LIU, Yujie, WU, Zhihao, QIN, Chao, WANG, Shengwu
• Format: Patent
• Language: English; French
• Published: 15.04.2021
• Subjects: CHEMISTRY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; ORGANIC CHEMISTRY; PEPTIDES; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

Disclosed herein are anti-CD20 antibody formulations and use of anti-CD20 antibodies for the treatment of CD20 positive diseases, such as methods of using anti-CD20 antibodies for treating CD20 positive diseases, such as neuromyelitis optica spectrum disorders (NMOSD), non-Hodgkin's lymphoma (NHL), multiple sclerosis (MS), immune thrombocytopenia (ITP), rheumatoid arthritis (RA), Wegener's granulomatosis (WG), microscopic polyangiitis (MPA), lupus nephritis, systemic lupus erythematosus and chronic lymphocytic leukemia (CLL). L'invention concerne des formulations d'anticorps anti-CD20 et l'utilisation d'anticorps anti-CD20 pour le traitement de maladies positives pour le CD20, ainsi que des méthodes d'utilisation d'anticorps anti-CD20 pour traiter des maladies positives pour le CD20, telles que des troubles du spectre de la neuromyélite optique (NMOSD), le lymphome non hodgkinien (NHL), la sclérose en plaques (MS), la thrombocytopénie Immunitaire (ITP), la polyarthrite rhumatoïde (RA), la granulomatose de Wegener (WG), la polyangéite microscopique (MPA), la néphropathie lupique, le lupus érythémateux disséminé et la leucémie lymphoïde chronique (CLL).